ReviewFrontiers in oncology2022

Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course.

Mengjie Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.